Branaplam is a small molecule RNA splicing modulator promoting changes in alternative splicing of the survival of motor neuron 2 (SMN2) mRNA1 and underwent clinical investigation in spinal muscular atrophy (SMA) (NCT02268552). The gene discussed is SMN2; the disease is proximal spinal muscular atrophy.